Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4021 AL 4035

NSAIDs Induced Regulation of Alternatively Spliced Transcript Isoforms: Possible Role in Cancer and Alzheimer Disease

Husain MA, Ur Rehman S, Sarwar T, Ishqi HM, Tabish M.

Curr Cancer Drug Targets. 2017;17(5):467-478. doi: 10.2174/1568009616666161216093403.

Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease

Ashok BS, Ajith TA, Sivanesan S.

Clin Exp Pharmacol Physiol. 2017 Mar;44(3):327-334. doi: 10.1111/1440-1681.12717.

Targeted Nanoparticles for the Treatment of Alzheimer's Disease

Martín-Rapun R, De Matteis L, Ambrosone A, Garcia-Embid S, Gutierrez L, de la Fuente JM.

Curr Pharm Des. 2017;23(13):1927-1952. doi: 10.2174/1381612822666161226151011.

Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy

Finke JM, Banks WA.

Hum Antibodies. 2017;25(3-4):131-146. doi: 10.3233/HAB-160306.

The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study

Gareri P, Castagna A, Cotroneo AM, Putignano D, Conforti R, Santamaria F, Marino S, Putignano S.

J Alzheimers Dis. 2017;56(2):557-565. doi: 10.3233/JAD-160808.

Editorial: Multitarget Molecules for Alzheimer's Disease Therapy

Marco-Contelles J, Fall Y.

Curr Top Med Chem. 2017;17(31):3318. doi: 10.2174/156802661731180221110409.

Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease

Goyal D, Shuaib S, Mann S, Goyal B.

ACS Comb Sci. 2017 Feb 13;19(2):55-80. doi: 10.1021/acscombsci.6b00116. Epub 2017 Jan 18.

Elucidating Treatment of Alzheimer's Disease via Different Receptors

Ul Islam B, Khan MS, Jabir NR, Kamal MA, Tabrez S.

Curr Top Med Chem. 2017;17(12):1400-1407. doi: 10.2174/1568026617666170103163715.

Alzheimer's Disease and Natural Products: Future Regimens Emerging from Nature

Islam MA, Khandker SS, Alam F, Khalil MI, Kamal MA, Gan SH.

Curr Top Med Chem. 2017;17(12):1408-1428. doi: 10.2174/1568026617666170103163054.

Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends

Bachurin SO, Bovina EV, Ustyugov AA.

Med Res Rev. 2017 Sep;37(5):1186-1225. doi: 10.1002/med.21434. Epub 2017 Jan 13.

Chronoinflammaging in Alzheimer; A systematic review on the roles of toll like receptor 2

Ravari A, Mirzaei T, Kennedy D, Kazemi Arababadi M.

Life Sci. 2017 Feb 15;171:16-20. doi: 10.1016/j.lfs.2017.01.003. Epub 2017 Jan 11.

Synaptic Plasticity, Dementia and Alzheimer Disease

Skaper SD, Facci L, Zusso M, Giusti P.

CNS Neurol Disord Drug Targets. 2017;16(3):220-233. doi: 10.2174/1871527316666170113120853.

The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind

Ricciarelli R, Fedele E.

Curr Neuropharmacol. 2017;15(6):926-935. doi: 10.2174/1570159X15666170116143743.

Update on Alzheimer's Disease Therapy and Prevention Strategies

Graham WV, Bonito-Oliva A, Sakmar TP.

Annu Rev Med. 2017 Jan 14;68:413-430. doi: 10.1146/annurev-med-042915-103753.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias